Sep 13, 2018
NIH selects Soligenix's SGX942 in the Treatment of Oral Mucositis for the Commercialization Accelerator Program
Sep 04, 2018
Ezer Mizion's #SharedLife Campaign Spearheading Urgent Donations To Facilitate Testing for Young Bride-To-Be; 27-year Old Leukemia Patient Given Mere Weeks To Live Without Successful Donor Match
Aug 29, 2018
European Commission Approves BLINCYTO® (blinatumomab) For Use In Pediatric Patients With Philadelphia Chromosome-Negative Relapsed Or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
Aug 27, 2018
Vyxeos® Receives Marketing Authorisation in the European Union for Treatment of Certain Types of High-Risk Acute Myeloid Leukaemia
Aug 20, 2018
NYU Langone's Blood & Marrow Transplant Program Expands Services
Aug 14, 2018
Actinium to Provide Update on Pivotal Phase 3 SIERRA Trial Following Positive Data Monitoring Committee Meeting
Aug 13, 2018
Information Update - Health Canada Warns Canadians of New Safety Information Related to Long-Term Use of Azithromycin Following Stem Cell Transplants in Cancer Treatment
Aug 08, 2018
Viracor Eurofins' Algorithms Predict Risk of aGVHD and Non-relapse Mortality in Allogeneic HCT Patients
Aug 07, 2018
BioLineRx Announces Positive Results of Lead-in Period for Phase 3 GENESIS Trial in Stem-Cell Mobilization
Jul 17, 2018
Cancer Survivor And Illusionist Jim Munroe Partners With Be The Match® To Make Cancer Disappear
Jul 05, 2018
Neovii & Mundipharma Confirm In-licensing Agreement for the Development and Promotion of Grafalon(R) in China and Japan for Solid Organ & Stem Cell Transplant
Jun 16, 2018
European Hematology Association: A New Anti-CD22 CAR-T Immunotherapy Saved Life of Children With Leukemia
Jun 16, 2018
Phase 3 QuANTUM-R Study Demonstrates Daiichi Sankyo's Quizartinib Significantly Prolongs Overall Survival as Single Agent Compared to Chemotherapy in Patients with Relapsed/Refractory AML with FLT3-ITD Mutations
Jun 13, 2018
Inaugural 'Blood Cancer In America' Survey Finds Patients Maintain Positive Views of Condition Being 'Under Control'
Jun 10, 2018
Cellenkos(TM), Inc. Announces FDA Clearance of Investigational New Drug Application for CK0801 for Bone Marrow Failure Syndromes
Jun 06, 2018
Partner Therapeutics (PTx) Announces US FDA Approval of Leukine® (sargramostim) for the Treatment of Acute Radiation Syndrome
May 17, 2018
BioLineRx Reports Results of Phase 2 Study for BL-8040 Monotherapy in Stem Cell Mobilization for Allogeneic Bone Marrow Transplantation
May 08, 2018
Daiichi Sankyo Announces Single Agent Quizartinib Significantly Prolongs Overall Survival Compared with Chemotherapy in Patients with Relapsed/Refractory AML with FLT3-ITD Mutations (QuANTUM-R Study)
Apr 18, 2018
StemCyte, Inc. Announces the Expansion of Two New Umbilical Cord Blood Collection Sites in Southern California
Apr 12, 2018
Three-Time Cancer Conqueror Who Completed Seven Marathons on Seven Continents After Relearning How to Walk Celebrates Fourteen-Year Anniversary of Bone Marrow Transplant